Align Technology Revenue 2006-2018 | ALGN

Current and historical revenue for Align Technology (ALGN) from 2006 to 2018. The sum of all revenue fields included for a company's operating activities. The current revenue for Align Technology as of March 31, 2018 is .
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.026B $1.473B
Align Technology, Inc. is a global medical device company with industry-leading innovative products such as Invisalign clear aligners, iTero Intraoral scanners, and OrthoCAD digital services that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients.
Stock Name Country Market Cap PE Ratio
Becton, Dickinson (BDX) United States $65.499B 24.54
McKesson (MCK) United States $27.357B 10.73
AmerisourceBergen (ABC) United States $19.101B 13.90
Laboratory Of America Holdings (LH) United States $18.998B 18.35
Cardinal Health (CAH) United States $15.755B 9.94
Cooper (COO) United States $11.918B 22.18
Henry Schein (HSIC) United States $11.410B 20.21
DENTSPLY SIRONA (XRAY) United States $10.171B 17.07
West Pharmaceutical Services (WST) United States $7.244B 40.35
Merit Medical Systems (MMSI) United States $2.803B 42.12
Patterson (PDCO) United States $2.134B 13.41
CONMED (CNMD) United States $2.051B 35.68
STAAR Surgical (STAA) United States $1.359B 466.43
Atrion (ATRI) United States $1.120B 32.00
Invacare (IVC) United States $0.680B 0.00
Endologix (ELGX) United States $0.463B 0.00
Antares Pharma (ATRS) United States $0.423B 0.00
Lifevantage (LFVN) United States $0.136B 28.18
Aceto (ACET) United States $0.101B 4.09
Pro-Dex (PDEX) United States $0.029B 12.79
Milestone Scientific (MLSS) United States $0.027B 0.00
Retractable Technologies (RVP) United States $0.027B 0.00
Biolase (BIOL) United States $0.026B 0.00